198 related articles for article (PubMed ID: 31401731)
1. Prothrombin Complex Concentrates are Superior to Fresh Frozen Plasma for Emergency Reversal of Vitamin K Antagonists: A Meta-Analysis in 2606 Subjects.
Hill R; Han TS; Lubomirova I; Math N; Bentley P; Sharma P
Drugs; 2019 Sep; 79(14):1557-1565. PubMed ID: 31401731
[TBL] [Abstract][Full Text] [Related]
2. Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trial.
Steiner T; Poli S; Griebe M; Hüsing J; Hajda J; Freiberger A; Bendszus M; Bösel J; Christensen H; Dohmen C; Hennerici M; Kollmer J; Stetefeld H; Wartenberg KE; Weimar C; Hacke W; Veltkamp R
Lancet Neurol; 2016 May; 15(6):566-73. PubMed ID: 27302126
[TBL] [Abstract][Full Text] [Related]
3. Benefits and harms of 4-factor prothrombin complex concentrate for reversal of vitamin K antagonist associated bleeding: a systematic review and meta-analysis.
Brekelmans MPA; Ginkel KV; Daams JG; Hutten BA; Middeldorp S; Coppens M
J Thromb Thrombolysis; 2017 Jul; 44(1):118-129. PubMed ID: 28540468
[TBL] [Abstract][Full Text] [Related]
4. Prothrombin complex concentrates to reverse warfarin-induced coagulopathy in patients with intracranial bleeding.
Cabral KP; Fraser GL; Duprey J; Gibbons BA; Hayes T; Florman JE; Seder DB
Clin Neurol Neurosurg; 2013 Jun; 115(6):770-4. PubMed ID: 22835715
[TBL] [Abstract][Full Text] [Related]
5. Reversal of coagulopathy using prothrombin complex concentrates is associated with improved outcome compared to fresh frozen plasma in warfarin-associated intracranial hemorrhage.
Frontera JA; Gordon E; Zach V; Jovine M; Uchino K; Hussain MS; Aledort L
Neurocrit Care; 2014 Dec; 21(3):397-406. PubMed ID: 24671832
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of prothrombin complex concentrate for vitamin K antagonist-associated intracranial hemorrhage: a systematic review and meta-analysis.
Pan R; Cheng J; Lai K; Huang Q; Wu H; Tang Y
Neurol Sci; 2019 Apr; 40(4):813-827. PubMed ID: 30689075
[TBL] [Abstract][Full Text] [Related]
7. Rapid Warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate.
Woo CH; Patel N; Conell C; Rao VA; Faigeles BS; Patel MC; Pombra J; Akins PT; Axelrod YK; Ge IY; Sheridan WF; Flint AC
World Neurosurg; 2014 Jan; 81(1):110-5. PubMed ID: 23220122
[TBL] [Abstract][Full Text] [Related]
8. Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal. A systematic review and meta-analysis.
Chai-Adisaksopha C; Hillis C; Siegal DM; Movilla R; Heddle N; Iorio A; Crowther M
Thromb Haemost; 2016 Oct; 116(5):879-890. PubMed ID: 27488143
[TBL] [Abstract][Full Text] [Related]
9. Mortality in vitamin K antagonist-related intracerebral bleeding treated with plasma or 4-factor prothrombin complex concentrate.
Majeed A; Meijer K; Larrazabal R; Arnberg F; Luijckx GJ; Roberts RS; Schulman S
Thromb Haemost; 2014 Feb; 111(2):233-9. PubMed ID: 24154891
[TBL] [Abstract][Full Text] [Related]
10. Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial.
Goldstein JN; Refaai MA; Milling TJ; Lewis B; Goldberg-Alberts R; Hug BA; Sarode R
Lancet; 2015 May; 385(9982):2077-87. PubMed ID: 25728933
[TBL] [Abstract][Full Text] [Related]
11. Inactivated Four-Factor Prothrombin Complex Concentrate Dosing Practices for Reversal of Warfarin-Related Intracranial Hemorrhage.
Rhoney DH; La M; Merz M; Cook A; Owusu KA; Roels C; Blunck J; Shewmaker J; Sangha KS; Farrokh S; Lewin J; Chester KW; Human T; Bledsoe K; Greene K; Levesque M; Rocker JC; Davis G; Neyens R; Lassiter TF; Adriance SM
Neurocrit Care; 2021 Aug; 35(1):130-138. PubMed ID: 33219462
[TBL] [Abstract][Full Text] [Related]
12. Prothrombin Complex Concentrate for Vitamin K Antagonist-Associated Intracranial Hemorrhage - Global Evidence and the Japanese Perspective.
Yasaka M; Brainsky A; Toyoda K
Circ J; 2017 Oct; 81(11):1564-1573. PubMed ID: 28724836
[TBL] [Abstract][Full Text] [Related]
13. Prevention of treatment-related fluid overload reduces estimated effective cost of prothrombin complex concentrate in patients requiring rapid vitamin K antagonist reversal.
Jones CA; Ducis K; Petrozzino J; Clark E; Fung MK; Peters C; Sarkar IN; Krol E; Pochal B; Boutrus A; Weimersheimer P; Freeman K
Expert Rev Pharmacoecon Outcomes Res; 2016; 16(1):135-9. PubMed ID: 26211539
[TBL] [Abstract][Full Text] [Related]
14. Safety and Effectiveness of Factor VIII Inhibitor Bypassing Activity (FEIBA) and Fresh Frozen Plasma in Oral Anticoagulant-Associated Intracranial Hemorrhage: A Retrospective Analysis.
Yin EB; Tan B; Nguyen T; Salazar M; Putney K; Gupta P; Suarez JI; Bershad EM
Neurocrit Care; 2017 Aug; 27(1):51-59. PubMed ID: 28243997
[TBL] [Abstract][Full Text] [Related]
15. Safety and effectiveness of a prothrombin complex concentrate in approved and off-label indications.
Marcos-Jubilar M; García Erce JA; Martínez-Calle N; Páramo JA; Martínez Virto A; Quintana-Díaz M
Transfus Med; 2019 Aug; 29(4):268-274. PubMed ID: 31347218
[TBL] [Abstract][Full Text] [Related]
16. Anticoagulation Reversal Strategies for Left Ventricular Assist Device Patients Presenting with Acute Intracranial Hemorrhage.
Wong JK; Chen PC; Falvey J; Melvin AL; Lidder AK; Lowenstein LM; Miranpuri AS; Knight PA; Massey HT
ASAIO J; 2016; 62(5):552-7. PubMed ID: 27347708
[TBL] [Abstract][Full Text] [Related]
17. Reversal strategies for vitamin K antagonists in acute intracerebral hemorrhage.
Parry-Jones AR; Di Napoli M; Goldstein JN; Schreuder FH; Tetri S; Tatlisumak T; Yan B; van Nieuwenhuizen KM; Dequatre-Ponchelle N; Lee-Archer M; Horstmann S; Wilson D; Pomero F; Masotti L; Lerpiniere C; Godoy DA; Cohen AS; Houben R; Al-Shahi Salman R; Pennati P; Fenoglio L; Werring D; Veltkamp R; Wood E; Dewey HM; Cordonnier C; Klijn CJ; Meligeni F; Davis SM; Huhtakangas J; Staals J; Rosand J; Meretoja A
Ann Neurol; 2015 Jul; 78(1):54-62. PubMed ID: 25857223
[TBL] [Abstract][Full Text] [Related]
18. A French multicenter randomised trial comparing two dose-regimens of prothrombin complex concentrates in urgent anticoagulation reversal.
Kerebel D; Joly LM; Honnart D; Schmidt J; Galanaud D; Negrier C; Kursten F; Coriat P;
Crit Care; 2013 Jan; 17(1):R4. PubMed ID: 23305460
[TBL] [Abstract][Full Text] [Related]
19. Race against the clock: overcoming challenges in the management of anticoagulant-associated intracerebral hemorrhage.
Le Roux P; Pollack CV; Milan M; Schaefer A
J Neurosurg; 2014 Aug; 121 Suppl():1-20. PubMed ID: 25081496
[TBL] [Abstract][Full Text] [Related]
20. Prothrombin complex concentrate (Octaplex) in patients requiring immediate reversal of oral anticoagulation.
Riess HB; Meier-Hellmann A; Motsch J; Elias M; Kursten FW; Dempfle CE
Thromb Res; 2007; 121(1):9-16. PubMed ID: 17407788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
